These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34033812)

  • 1. A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia.
    Costantine MM; West H; Wisner KL; Caritis S; Clark S; Venkataramanan R; Stika CS; Rytting E; Wang X; Ahmed MS;
    Am J Obstet Gynecol; 2021 Dec; 225(6):666.e1-666.e15. PubMed ID: 34033812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial.
    Costantine MM; Cleary K; Hebert MF; Ahmed MS; Brown LM; Ren Z; Easterling TR; Haas DM; Haneline LS; Caritis SN; Venkataramanan R; West H; D'Alton M; Hankins G;
    Am J Obstet Gynecol; 2016 Jun; 214(6):720.e1-720.e17. PubMed ID: 26723196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia.
    Döbert M; Varouxaki AN; Mu AC; Syngelaki A; Ciobanu A; Akolekar R; De Paco Matallana C; Cicero S; Greco E; Singh M; Janga D; Del Mar Gil M; Jani JC; Bartha JL; Maclagan K; Wright D; Nicolaides KH
    Circulation; 2021 Aug; 144(9):670-679. PubMed ID: 34162218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction.
    Jurisic A; Jurisic Z; Lefkou E; Girardi G
    Vascul Pharmacol; 2021 Apr; 137():106824. PubMed ID: 33249273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin for the prevention of preeclampsia in high-risk pregnant women.
    Costantine MM; Cleary K;
    Obstet Gynecol; 2013 Feb; 121(2 Pt 1):349-353. PubMed ID: 23344286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia.
    Paidas MJ; Tita ATN; Macones GA; Saade GA; Ehrenkranz RA; Triche EW; Streisand JB; Lam GK; Magann EF; Lewis DF; Dombrowski MP; Werner EF; Branch DW; Habli MA; Grotegut CA; Silver RM; Longo SA; Amon E; Cleary KL; How HY; Novotny SR; Grobman WA; Whiteman VE; Wing DA; Scifres CM; Sibai BM
    Am J Obstet Gynecol; 2020 Nov; 223(5):739.e1-739.e13. PubMed ID: 32780999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial.
    Ahmed A; Williams DJ; Cheed V; Middleton LJ; Ahmad S; Wang K; Vince AT; Hewett P; Spencer K; Khan KS; Daniels JP;
    BJOG; 2020 Mar; 127(4):478-488. PubMed ID: 31715077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial.
    Cluver CA; Hannan NJ; van Papendorp E; Hiscock R; Beard S; Mol BW; Theron GB; Hall DR; Decloedt EH; Stander M; Adams KT; Rensburg M; Schubert P; Walker SP; Tong S
    Am J Obstet Gynecol; 2018 Oct; 219(4):388.e1-388.e17. PubMed ID: 30055127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
    Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
    J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.
    Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.
    McLaughlin K; Hobson SR; Chandran AR; Agrawal S; Windrim RC; Parks WT; Bowman AW; Sovio U; Smith GC; Kingdom JC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1145-S1156.e1. PubMed ID: 34461078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Hoffman MK; Goudar SS; Kodkany BS; Metgud M; Somannavar M; Okitawutshu J; Lokangaka A; Tshefu A; Bose CL; Mwapule A; Mwenechanya M; Chomba E; Carlo WA; Chicuy J; Figueroa L; Garces A; Krebs NF; Jessani S; Zehra F; Saleem S; Goldenberg RL; Kurhe K; Das P; Patel A; Hibberd PL; Achieng E; Nyongesa P; Esamai F; Liechty EA; Goco N; Hemingway-Foday J; Moore J; Nolen TL; McClure EM; Koso-Thomas M; Miodovnik M; Silver R; Derman RJ;
    Lancet; 2020 Jan; 395(10220):285-293. PubMed ID: 31982074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia.
    Wright D; Poon LC; Rolnik DL; Syngelaki A; Delgado JL; Vojtassakova D; de Alvarado M; Kapeti E; Rehal A; Pazos A; Carbone IF; Dutemeyer V; Plasencia W; Papantoniou N; Nicolaides KH
    Am J Obstet Gynecol; 2017 Dec; 217(6):685.e1-685.e5. PubMed ID: 28888591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up.
    Fruci S; Salvi S; Moresi S; Gallini F; Dell'Aquila M; Arena V; Di Stasio E; Ferrazzani S; De Carolis S; Lanzone A
    Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():37-42. PubMed ID: 36764034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit.
    Wright D; Rolnik DL; Syngelaki A; de Paco Matallana C; Machuca M; de Alvarado M; Mastrodima S; Tan MY; Shearing S; Persico N; Jani JC; Plasencia W; Papaioannou G; Molina FS; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jun; 218(6):612.e1-612.e6. PubMed ID: 29505771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race.
    Tolcher MC; Sangi-Haghpeykar H; Mendez-Figueroa H; Aagaard KM
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100184. PubMed ID: 33345910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial.
    Groom KM; McCowan LM; Mackay LK; Lee AC; Said JM; Kane SC; Walker SP; van Mens TE; Hannan NJ; Tong S; Chamley LW; Stone PR; McLintock C;
    Am J Obstet Gynecol; 2017 Mar; 216(3):296.e1-296.e14. PubMed ID: 28153659
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.